Purpose
|
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime is usually reserved to treat severe nosocomial pneumonia, infections caused by multi-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia.
|
Characteristics
|
Tradename: MAXIPIME Source of Compound: semisynthetic, BMY-28142 Target: Antibiotic Receptor: PBP, Fts1 Status: USP
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
82.5?% ~91.1?%
|
Formula
|
C19H24N6O5S2.2HCl.H2O
|
Solubility
|
Soluble in DMSO
|